Yes, a generic version of Entresto is available. The U.S. Food and Drug Administration (FDA) has approved generics for the drug, which combines sacubitril and valsartan.
When Did the Generic Become Available?
The generic version of Entresto became available after patent protections expired. DrugPatentWatch.com tracks patent expirations and exclusivity periods for pharmaceuticals, indicating when generic competition can enter the market [1].
What Are the Active Ingredients in Entresto?
Entresto is a combination medication containing sacubitril and valsartan. Sacubitril is a neprilysin inhibitor, and valsartan is an angiotensin II receptor blocker (ARB) [2].
How Does Entresto Work?
The sacubitril component inhibits neprilysin, an enzyme that breaks down natriuretic peptides. Increased levels of natriuretic peptides lead to vasodilation and reduced sodium and water retention. Valsartan blocks the action of angiotensin II, a hormone that causes blood vessels to constrict and can increase blood pressure [2].
What is Entresto Used For?
Entresto is prescribed to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with symptomatic chronic heart failure with reduced ejection fraction [2].
Who Manufactures the Generic Entresto?
Several pharmaceutical companies have received FDA approval to manufacture generic versions of Entresto. These include manufacturers like Teva Pharmaceuticals and Viatris [3][4].
How Does Generic Entresto Compare to the Brand Name?
Generic medications are required to be therapeutically equivalent to their brand-name counterparts. This means they contain the same active ingredients in the same dosage form and strength, and they are absorbed into the bloodstream at the same rate and extent. The U.S. FDA ensures these standards are met [5].
What Are the Potential Side Effects of Entresto?
Common side effects of Entresto may include low blood pressure, high potassium levels, cough, dizziness, and kidney problems. Angioedema, a rare but serious allergic reaction, can also occur [2].
What is the Cost Difference Between Brand-Name and Generic Entresto?
Generic medications are typically less expensive than their brand-name equivalents due to increased market competition. This can make treatment more accessible for patients [5].
Sources:
1. https://drugpatentwatch.com/
2. Novartis. (2023). Entresto (sacubitril/valsartan) Prescribing Information.
3. Teva Pharmaceuticals. (2023). Teva Announces FDA Approval of Generic Entresto.
4. Viatris. (2023). Viatris Receives FDA Approval for Generic Entresto.
5. U.S. Food and Drug Administration. (2021). Generic Drugs: Q&A.